Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets (NCT07502495)
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets Despite Antihyperglycemic Medications
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 2, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic medications.
Who can join: Review the eligibility criteria below.
Location: Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama
- Hope Clinical Research — Canoga Park, California
- Ark Clinical Research — Fountain Valley, California
- Ark Clinical Research — Long Beach, California
- Catalina Research Institute, LLC — Montclair, California
- Paradigm Clinical Research Centers, LLC — San Diego, California
- Southwest General Healthcare Center — Fort Myers, Florida
- Panax Clinical Research — Miami Lakes, Florida
- Clinical Site Partners, LLC dba Flourish Research — Winter Park, Florida
- David Kavtaradze MD, Inc — Cordele, Georgia
- Excel Clinical Research — Las Vegas, Nevada
- Diabetes and Endocrinology Associates of Stark County — Canton, Ohio
- Elligo Health Research, Inc. — Austin, Texas
- Zenos Clinical Research — Dallas, Texas
- Synergy Groups Medical — Houston, Texas
- Epic Clinical Research — Lewisville, Texas
- Synergy Group Medical LLC — Missouri City, Texas
- Manassas Clinical Research Center — Manassas, Virginia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Type 2 Diabetes
- Continuous Glucose Monitoring System Feasibility in Youth With T2D — San Francisco, California
- Diabetes Nutrition Education and Healthy Food Resource for AIANs With T2D — Oklahoma City, Oklahoma
- Personalized Nutrition Therapy Using Continuous Glucose Monitoring to Improve Outcomes in Type 2 Diabetes Mellitus — Minneapolis, Minnesota
- Diabetes Medical Nutrition Therapy in Southeastern African American Women — Nashville, Tennessee
- E3 Diabetes - Closing the Gap in Diabetes Control — Chicago, Illinois
- Recreational Basketball to Increase Participation in Diabetes Prevention — Atlanta, Georgia
Explore by condition: All Type 2 Diabetes clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.